Validating PRL2 as a New Therapeutic Target in T-ALL

Julia Travagline 11/20/24 Julia Travagline 11/20/24

Validating PRL2 as a New Therapeutic Target in T-ALL

Validating PRL2 as a New Therapeutic Target in T-ALL

Dr. Loretta Li, M.D. – Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL

Julia Travagline 8/10/21 Julia Travagline 8/10/21

Pediatric Cancer Data Commons

Pediatric Cancer Data Commons

University of Chicago, Chicago, Illinois

Julia Travagline 8/9/21 Julia Travagline 8/9/21

Targeting MEK and CDK4/6 in DIPG

Targeting MEK and CDK4/6 in DIPG

Lurie Children’s Hospital, Chicago, IL